Skip to content
Delayed ~15 min

ORKA ORUKA THERAPEUTICS INC

Health Care · Russell 2000

Next earnings: Wed 11 Nov 2026 · estimated

What 17 analyst firms say about ORUKA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

102.86 USD+6.84 (+7.12%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+35.0%to the avg target 138.86 USD+36.00 USD
Buy 14 · Hold 1 · Sell 0

15 rated views · 17 analyst/firm records · 17 firms

Latest report27 Oct 2026avg report date 6 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8066
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8066

Recent analyst activity · last 90 days

Our tracked history has 19 reports on ORKA from 10 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 5 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Piper Sandler raised its target from $75.00 (set 18 Dec 2025) to $180.00 on 23 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BarclaysEtzer DaroutBuy11 Aug 2026160.00 USD
BTIGJulian HarrisonBuy19 Oct 2026151.00 USD
Clear Street LLCKaveri PohlmanBuy3 Aug 2026Conflicting reports · excluded
GuggenheimYastin SunejaBuy26 Oct 2026200.00 USD
H.C. WainwrightMitchell S. KapoorBuy27 Oct 2026120.00 USD · 24 Sep 2026
JefferiesRoger SongBuy11 Aug 2026133.00 USD
Leerink PartnersDavid RisingerBuy20 Jul 2026179.00 USD
Lifesci CapitalSam SlutskyBuy13 Mar 2026125.00 USD
MizuhoUnnamed analyst—3 Sep 2026120.00 USD
Piper SandlerYasmeen RahimiBuy7 Oct 2026180.00 USD · 23 Sep 2026
StifelAlex ThompsonBuy13 Mar 202672.00 USD
TD CowenTyler Van BurenBuy24 Mar 2026—
UBSMichael YeeBuy1 Jul 2026130.00 USD
WedbushMartin FanBuy27 Oct 2026165.00 USD
Weiss RatingsUnnamed analyst—13 Oct 2026—
Wolfe ResearchAndy G ChenBuy31 Aug 2026117.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 202692.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 02:41 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.